Results 111 to 120 of about 3,460 (162)

Risk factors for cerebral infarction in patients with rheumatoid arthritis: a retrospective case-control study. [PDF]

BMC Neurol
Xuan J, Gao X.
europepmc   +1 more source

Cellular miRNA-31 and miRNA-125b as predictors of remission and major disease improvement in patients with early rheumatoid arthritis. [PDF]

Sci Rep
Horváthová V, Vernerová L, Prajzlerová K, Kropáčková T, Komarc M, Mann H, Filková M, Pavelka K, Vencovský J, Šenolt L.   +9 more
europepmc   +1 more source

Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors. [PDF]

RMD Open
Giollo A, Di Luozzo L, Salvato M, Khalid K, D'Andrea R, Benetti A, Samà C, Ramonda R, Simioni P, Spiezia L.   +9 more
europepmc   +1 more source

Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients. [PDF]

Rheumatol Int
Flouri I, Bertsias A, Zoupidou K, Koutsianas C, Fragoulis G, Nezis-Katsifis D, Sambatakaki E, Avgoustidis N, Repa A, Bertsias G, Tektonidou M, Sfikakis P, Vassilopoulos D, Boumpas D, Sidiropoulos P.   +14 more
europepmc   +1 more source

Serum low-density lipoprotein and synovial vascularity in patients with active rheumatoid arthritis and psoriatic arthritis. [PDF]

Reumatologia
Jakubaszek M, Kwiatkowska B, Płaza M, Maślińska M.   +3 more
europepmc   +1 more source

Integration of synovial pathotypes and serum proteomic modules as determinants of disease progression and therapeutic response in early rheumatoid arthritis. [PDF]

RMD Open
Corrales S, Osuna-Soto J, Cid-Chaves A, Ortega-Castro R, Ladehesa-Pineda L, Merlo-Ruiz C, Ruiz-Vílchez D, Barbarroja N, Leiva-Cepas F, Perez-Sanchez C, Alarcón-Riquelme M, Aranda-Valera C, Escudero-Contreras A, López-Pedrera C.   +13 more
europepmc   +1 more source

Traditional clinical risk factors outperform disease activity and hematologic indices for FRAX hip fracture risk in rheumatoid arthritis. [PDF]

Front Immunol
Zhang L, Wang Y, Li X, Li SG, Jin D.
europepmc   +1 more source

Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohort. [PDF]

RMD Open
Fadlallah S, Fraussen J, Ruytinx P, Sokolova T, Verschueren P, Durez P, Somers V.   +6 more
europepmc   +1 more source

Baseline Interleukin-10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease-Modifying Antirheumatic Drug Naive and Anti-Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis. [PDF]

Arthritis Rheumatol
Liu J, Li Y, Fu K, Wu C, Schafer P, Connolly SE, Catlett IM, Maldonado MA, Wong R, Emery P, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TWJ, Fleischmann R.   +14 more
europepmc   +1 more source

Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial. [PDF]

EClinicalMedicine
Tas SW, Christiaans J, Boumans MJH, Koopman FA, Pickrell P, Goddard DH, Kivitz A, Patel-Banker M, Chu CQ, Lee E, Wickersham P, Alli VV, Faulkenberry TL, Jenkins M, Winder J, Luyer MDP, Barnett C, Famm K, Irwin E, Kwong K, Scribner LL, Milliken PH, Raji O, Rall K, Sokal DM, Whiteman H, Mahmood A, Vervoordeldonk MJ, Gupta I, Abdulai RM, Broen JCA.   +30 more
europepmc   +1 more source